Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Adult male patients diagnosed with CRPC with symptomatic bone metastases without known visceral metastases
Decision to initiate treatment with Radium-223 was made as per investigator's routine treatment practice
You may not be if
Patients participating in an investigational program with interventions outside of routine clinical practice or participating in another observational study with Xofigo
Clareo Health | Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases
